Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

10.6K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.6K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.5K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Understanding quantitative effects of anti-amyloid therapies on tau biomarkers and functional outcome. Insights from a comprehensive mechanistic quantitative systems pharmacology study.

Frontiers in pharmacology·2026
Same author

Drug Development.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Developing Topics.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Developing Topics.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Developing Topics.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Interactions of Therapeutic Antibodies With Presynaptically-Released Misfolded Proteins in Neurodegenerative Diseases. A Spatial Monte-Carlo Simulation Study.

CPT: pharmacometrics & systems pharmacology·2025
Same journal

In-silico investigation of Agelas marine sponge-derived bioactive compounds as inhibitors of estrogen receptor alpha against breast cancer.

In silico pharmacology·2026
Same journal

Design, synthesis, and biological evaluation of p-thymol-derived 1,2,4-triazole sulfonyl hydrazides as potent α-amylase and α-glucosidase inhiabitors: molecular docking and ADME insights.

In silico pharmacology·2026
Same journal

Network pharmacology-guided identification of kinase-mediated vascular signalling targets underlying the antihypertensive potential of <i>Brassica rapa</i> L.

In silico pharmacology·2026
Same journal

Integrated in vivo and in silico evaluation of <i>Coccinia grandis</i> (L.) Voigt root constituents reveals dual targeting of 5-HT<sub>3</sub>A and D<sub>2</sub> receptors in emesis.

In silico pharmacology·2026
Same journal

Hinokitiol identified from <i>Phyllanthus fraternus</i> leaves a potential therapeutic solution for hepatocellular carcinoma: a network pharmacology-based study.

In silico pharmacology·2026
Same journal

Integrated synthesis and computational assessment of sulfanilamide-triazolo-oxadiazole triads as effective ALP and amylase inhibitors.

In silico pharmacology·2026
See all related articles

Related Experiment Video

Updated: Nov 27, 2025

Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases
09:44

Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases

Published on: May 2, 2025

473

Re-engineering CNS drug discovery and development using computer aided modeling

Hugo Geerts1

  • 1Head Neuroscience QSP, Certara-SimCyp, Sheffield, UK.

In Silico Pharmacology
|December 3, 2020
PubMed
Summary

No abstract available in PubMed .

More Related Videos

Engineered 3D Silk-collagen-based Model of Polarized Neural Tissue
06:17

Engineered 3D Silk-collagen-based Model of Polarized Neural Tissue

Published on: October 23, 2015

12.8K
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.0K

Related Experiment Videos

Last Updated: Nov 27, 2025

Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases
09:44

Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases

Published on: May 2, 2025

473
Engineered 3D Silk-collagen-based Model of Polarized Neural Tissue
06:17

Engineered 3D Silk-collagen-based Model of Polarized Neural Tissue

Published on: October 23, 2015

12.8K
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.0K